DUBLIN--(BUSINESS WIRE)-- ICON plc (ICLR), (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of ...

Icon Plc (NASDAQ: ICLR) shares are crashing in Thursday’s premarket session as the company disclosed an update on its upcoming earnings report. The clinical research organisation disclosed an ongoing ...

DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announces that it is partnering with the U.S. Biomedical Advanced ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured with numerous awards in the second half of 2024. On TIME ...

Adoption allows ICON to take full advantage of the Medidata “Data Experience,” leveraging AI to unify data sources, standardize outputs, and reduce reconciliation efforts “ICON leads in risk-based ...

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired ...

DUBLIN, January 27, 2026--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR) today announced a significant expansion of oncology research capabilities within its Accellacare Site Network through the opening of ...

We recently published a list of 10 AI News and Ratings Too Important to Miss. In this article, we are going to take a look at where ICON Public Limited Company (NASDAQ:ICLR) stands against other AI ...

Clinical research organization ICON plc (NASDAQ:ICLR) announced its financial guidance for fiscal year 2025 on Tuesday. What Happened: The Dublin-based company forecasts revenues of $8.05 billion — $8 ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial ...

DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announces that it has been selected by the US Biomedical Advanced ...